Headlines

Republic Bancorp And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – Republic Bancorp (RBCAA), Agnico Eagle Mines Limited (AEM), Agree Realty Corporation (ADC) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Republic Bancorp (RBCAA)

27% sales growth and 10.55% return on equity

Republic Bancorp, Inc., a financial holding company, provides various banking products and services in the United States. It operates in five segments: Traditional Banking, Warehouse, Mortgage Banking, Tax Refund Solutions, and Republic Credit Solutions. The company accepts demand, money market accounts, savings, individual retirement accounts, time, brokered, and other certificates of deposit. Its loan products include residential real estate, commercial real estate, construction and land development, home improvement and home equity, secured and unsecured personal, and aircraft loans. The company also offers credit cards; title insurance and other financial products and services; and memory banking, private banking, lockbox processing, remote deposit capture, business online banking, account reconciliation, automated clearing house processing, and internet and mobile banking services. In addition, it provides short-term and revolving credit facilities to mortgage bankers; tax refund solutions, which facilitate the receipt and payment of federal and state tax refund products through third-party tax preparers and tax-preparation software providers; and general purpose reloadable prepaid cards through third party service providers. Further, the company offers consumer credit products; and property and casualty insurance products. As of January 28, 2022, it operated 42 full-service banking centers. Republic Bancorp, Inc. was incorporated in 1974 and is headquartered in Louisville, Kentucky.

Earnings Per Share

As for profitability, Republic Bancorp has a trailing twelve months EPS of $4.59.

PE Ratio

Republic Bancorp has a trailing twelve months price to earnings ratio of 9.19. Meaning, the purchaser of the share is investing $9.19 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.55%.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Jun 14, 2023, the estimated forward annual dividend rate is 1.5 and the estimated forward annual dividend yield is 3.55%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 10.8%, now sitting on 294.76M for the twelve trailing months.

Moving Average

Republic Bancorp’s worth is higher than its 50-day moving average of $40.32 and below its 200-day moving average of $42.27.

2. Agnico Eagle Mines Limited (AEM)

21.1% sales growth and 13.14% return on equity

Agnico Eagle Mines Limited engages in the exploration, development, and production of mineral properties in Canada, Mexico, and Finland. The company operates through Northern Business and Southern Business segments. It primarily produces and sells gold deposit, as well as explores for silver, zinc, and copper deposits. The company's flagship property is the LaRonde mine located in the Abitibi region of northwestern Quebec, Canada. As of December 31, 2019, its LaRonde mine had a mineral reserve of approximately 2.9 million ounces of gold. The company is also involved in exploration activities in Europe, Latin America, and the United States. Agnico Eagle Mines Limited was founded in 1953 and is headquartered in Toronto, Canada.

Earnings Per Share

As for profitability, Agnico Eagle Mines Limited has a trailing twelve months EPS of $4.95.

PE Ratio

Agnico Eagle Mines Limited has a trailing twelve months price to earnings ratio of 10.86. Meaning, the purchaser of the share is investing $10.86 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.14%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 32% and positive 3.8% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 13.9%, now sitting on 5.93B for the twelve trailing months.

Moving Average

Agnico Eagle Mines Limited’s worth is under its 50-day moving average of $54.33 and higher than its 200-day moving average of $49.14.

3. Agree Realty Corporation (ADC)

19.2% sales growth and 3.74% return on equity

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of June 30, 2020, the Company owned and operated a portfolio of 936 properties, located in 46 states and containing approximately 18.4 million square feet of gross leasable area. The common stock of Agree Realty Corporation is listed on the New York Stock Exchange under the symbol "ADC".

Earnings Per Share

As for profitability, Agree Realty Corporation has a trailing twelve months EPS of $1.79.

PE Ratio

Agree Realty Corporation has a trailing twelve months price to earnings ratio of 36.91. Meaning, the purchaser of the share is investing $36.91 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.74%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Agree Realty Corporation’s EBITDA is 17.99.

Yearly Top and Bottom Value

Agree Realty Corporation’s stock is valued at $66.06 at 01:22 EST, way under its 52-week high of $80.44 and higher than its 52-week low of $63.34.

4. Medpace Holdings (MEDP)

16.8% sales growth and 53.97% return on equity

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services to the biotechnology, pharmaceutical, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Earnings Per Share

As for profitability, Medpace Holdings has a trailing twelve months EPS of $7.81.

PE Ratio

Medpace Holdings has a trailing twelve months price to earnings ratio of 27. Meaning, the purchaser of the share is investing $27 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 53.97%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 31.2%, now sitting on 1.56B for the twelve trailing months.

5. Eli Lilly and Company (LLY)

14.7% sales growth and 54.79% return on equity

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Earnings Per Share

As for profitability, Eli Lilly and Company has a trailing twelve months EPS of $6.28.

PE Ratio

Eli Lilly and Company has a trailing twelve months price to earnings ratio of 68. Meaning, the purchaser of the share is investing $68 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 54.79%.

Sales Growth

Eli Lilly and Company’s sales growth is 16.1% for the present quarter and 14.7% for the next.

Moving Average

Eli Lilly and Company’s worth is way higher than its 50-day moving average of $387.29 and way above its 200-day moving average of $350.87.

6. United Airlines (UAL)

10.9% sales growth and 37.31% return on equity

United Airlines Holdings, Inc., through its subsidiaries, provides air transportation services in North America, Asia, Europe, Africa, the Pacific, the Middle East, and Latin America. The company transports people and cargo through its mainline and regional fleets. It also offers catering, ground handling, training, and maintenance services for third parties. The company was formerly known as United Continental Holdings, Inc. and changed its name to United Airlines Holdings, Inc. in June 2019. United Airlines Holdings, Inc. was incorporated in 1968 and is headquartered in Chicago, Illinois.

Earnings Per Share

As for profitability, United Airlines has a trailing twelve months EPS of $5.94.

PE Ratio

United Airlines has a trailing twelve months price to earnings ratio of 7.94. Meaning, the purchaser of the share is investing $7.94 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 37.31%.

Volume

Today’s last reported volume for United Airlines is 3614420 which is 53.43% below its average volume of 7761290.

Yearly Top and Bottom Value

United Airlines’s stock is valued at $47.17 at 01:22 EST, way under its 52-week high of $55.04 and way above its 52-week low of $31.58.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 158.7% and 21%, respectively.

7. Franklin Electric Co. (FELE)

5.5% sales growth and 19.06% return on equity

Franklin Electric Co., Inc., together with its subsidiaries, designs, manufactures, and distributes water and fuel pumping systems worldwide. It operates through three segments: Water Systems, Fueling Systems, and Distribution. The Water Systems segment offers submersible motors, pumps, drives, electronic controls, water treatment systems, monitoring devices, and related parts and equipment. Its motors and pumps are used principally for pumping clean water and wastewater in various residential, agricultural, municipal, and industrial applications; and manufactures electronic drives and controls that are used in motors for controlling functionality, as well as provides protection from various hazards, such as electrical surges, over-heating, and dry wells or tanks. The Fueling Systems segment provides pumps, pipes, sumps, fittings, vapor recovery components, electronic controls, monitoring devices, and related parts and equipment primarily for use in fueling system applications. This segment serves other energy markets, such as power reliability systems, as well as includes electronic devices for online monitoring of the power utility, hydroelectric, and telecommunication and data center infrastructure. The Distribution segment sells to and provides presale support and specifications to the installing contractors. It sells products produced by the Water Systems segment. The company sells its products to wholesale and retail distributors, specialty distributors, original equipment manufacturers, industrial and petroleum equipment distributors, and oil and utility companies through its employee sales force and independent manufacturing representatives. Franklin Electric Co., Inc. was founded in 1944 and is headquartered in Fort Wayne, Indiana.

Earnings Per Share

As for profitability, Franklin Electric Co. has a trailing twelve months EPS of $4.13.

PE Ratio

Franklin Electric Co. has a trailing twelve months price to earnings ratio of 22.41. Meaning, the purchaser of the share is investing $22.41 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.06%.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on May 2, 2023, the estimated forward annual dividend rate is 0.9 and the estimated forward annual dividend yield is 0.98%.

Leave a Reply

Your email address will not be published. Required fields are marked *